3D Systems Corporation develops additive manufacturing and digital manufacturing solutions built around 3D printers, materials, software and application engineering services. Its news commonly covers production systems for polymers and metals, NextDent dental printing and materials, SLA technology, factory software such as AddiTrak, and customer deployments in medical, dental, aerospace, defense, transportation, motorsports and industrial markets.
Company updates also include financial results, cost and efficiency programs, leadership changes, regulatory certifications for dental products, and commercial adoption of healthcare and industrial applications. These developments reflect the company’s focus on full-service solutions that combine hardware, materials, software and manufacturing expertise.
3D Systems Corporation (NYSE: DDD) reported Q4 2021 revenue of $150.9 million, a 12.6% decline from Q4 2020, attributed to divestitures. However, adjusted for these divestitures, revenue rose 13.1%. The full-year revenue reached $615.6 million, a 10.5% year-over-year increase. GAAP loss per share was $0.05, while non-GAAP income per share was $0.09. The company announced plans to acquire Titan Robotics and Kumovis, enhancing their technology suite. 2022 revenue guidance is set between $570 million and $630 million, with non-GAAP gross margins expected to be 40%-44%.
3D Systems has announced the acquisition of Kumovis, a Munich-based company specializing in additive manufacturing for personalized healthcare solutions. This acquisition enhances 3D Systems' capabilities in 3D printing medical devices using high-performance polymers like PEEK, which are ideal for implants and surgical tools. The transaction is expected to close in April 2022 and will expand 3D Systems' market for personalized healthcare applications. Regulatory clearance for the technology is anticipated within the year, promising improved patient outcomes through tailored solutions.
3D Systems (NYSE: DDD) announced the acquisition of Titan Additive LLC, a leader in large-format industrial 3D printing. This purchase aims to enhance 3D Systems' polymer technology portfolio and unlock new market opportunities across various sectors including aerospace, automotive, and consumer goods. Titan's unique extrusion technology offers modular designs with both filament and pellet capabilities, promising lower production costs and higher performance. The transaction is expected to close in April 2022, with further insights to be shared during the upcoming earnings call on February 28, 2022.
3D Systems and Saremco Dental AG have formed a strategic partnership to enhance digital dentistry through the introduction of CROWNTEC™ material in the U.S. This new composite resin is 30% stronger than previous crown & bridge materials and enables the production of biocompatible crowns and restorations using 3D Systems' NextDent® 5100 digital dentistry solution. CROWNTEC is CE-marked and has received 510(k) clearance, available in various shades to ensure natural aesthetics. This collaboration aims to improve efficiency and patient outcomes in dental labs and clinics.
3D Systems (NYSE:DDD) will release its financial results for Q4 and full year 2021 on February 28, 2022, after U.S. markets close. A conference call and webcast will take place the same day at 4:30 p.m. Eastern Time to discuss these results. The company will also file its Form 10-K on March 1, 2022. 3D Systems is a leader in Additive Manufacturing with over 30 years of innovation, offering a range of solutions for sectors like healthcare, aerospace, and automotive.
3D Systems (NYSE:DDD) will present virtually at the 24th Annual Needham Virtual Growth Conference on January 12, 2022, at 10:45 a.m. ET. Investors can access the live webcast in the 'Events and Presentations' section of the company’s website, where it will also be available for replay for at least 30 days post-event. The press release includes forward-looking statements with associated risks and uncertainties that may impact future performance. 3D Systems continues to be a leader in additive manufacturing, offering innovative solutions across healthcare and industrial markets.
3D Systems announced the immediate appointment of Claudia Napal Drayton to its Board of Directors. Drayton, who is currently the CFO of Quantum-Si, brings extensive experience in finance and the healthcare sector, notably from her prior role at Medtronic. The board's chairman, Chip McClure, highlighted her expertise as invaluable for future growth in medical devices and regenerative medicine. Drayton expressed enthusiasm for the company's innovative potential in healthcare applications, emphasizing opportunities for growth and value creation.
3D Systems has successfully completed an upsized offering of $460 million in 0% convertible senior notes due 2026. The offering includes $60 million from the initial purchasers' option. The notes do not accrue interest and will mature on November 15, 2026. They have an initial conversion rate of 27.8364 shares per $1,000 principal amount, representing a 42.5% premium over the recent stock price. Net proceeds of approximately $446 million will be used for general corporate purposes, including potential acquisitions. The offering was made to qualified institutional buyers under Rule 144A.
3D Systems (NYSE: DDD) has unveiled several innovations aimed at advancing additive manufacturing across healthcare and industrial sectors. Key highlights include the launch of the SLS 380 for enhanced part production, the DMP Flex 350 Dual and DMP Factory 350 Dual which reduce build times significantly, and the DMP Flex 200 optimized for dental applications. Additional advancements include the 3DXpert® 17 software for improved design workflows and the Figure 4® Rigid 140C Black material for automotive applications, showcasing the company's commitment to delivering innovative solutions in 3D printing.
3D Systems has priced its offering of $400 million in 0% convertible senior notes due 2026, raising the initial offering from $350 million. The sale is expected to close on November 16, 2021. The notes, with a conversion rate of 27.8364 shares per $1,000 principal, represent a 42.5% premium over the recent stock price. Estimated net proceeds are around $388 million, intended for general corporate purposes, including potential acquisitions. The offering is made under Rule 144A and involves risks that could affect the company's future performance.